Form 4 for SABS SAB Biotherapeutics, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001209191-22-060442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-09 | 2022-12-07 | SABS | Spragens Jeffrey G | Dir | A - Grant | $1.21 | +83.0K | 395.0K | +27% | +$100.4K |
| D | 2022-12-09 | 2022-12-07 | SABS | Spragens Jeffrey G | Dir | A - Grant | — | +83.0K | 83.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-07 | A | A | 82,987 | $1.21 | 394,989 | D | — | — | (F1) On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the "Shares") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance. |
| 2 | Derivative | Warrant (Common Stock) | 2022-12-07 | A | A | 82,987 | — | 82,987 | D | $1.08 · 2023-06-07 to 2027-12-07 | 82,987 Common Stock | (F1) On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the "Shares") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance. |